Taking place on Tuesday, 10th November, the theme for this year’s event is ‘Broader horizons: growing Europe’s health partnership’.

Sure to be an interesting online event, it will focus on pediatric cancers and demonstrate how a new partnership will bring stakeholders together, synergizing with the Cancer Mission to be more inclusive in the co-creation of ideas for the program.

The free-of-charge event strives to get the widest audience possible from health and medicines R&D together. Aimed at policymakers, academics, pharmaceutical/ medical technology industries, patient representatives, regulators, and health NGOs, it’s set to discuss ideas to help develop the new partnership, avoid pitfalls and build together a world-leading collaboration.

The event will include leaders in both policymaking and science and technology, and feature a closing speech from Member of the European Parliament Maria Da Graça Carvalho; perfectly demonstrating the Innovative Medicines Initiative (IMI) public-private partnership between the EU and EFPIA – European Federation of Pharmaceutical Industries and Associations.

Follow us on LinkedIn for more industry news and events.

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.